SUPERIOR VENA CAVAL OCCLUSION

SUPERIOR VENA CAVAL OCCLUSION was reported 126 times

SUPERIOR VENA CAVAL OCCLUSION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Paramagnetic Contrast Agent [EPC] 2 0.0004
1 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 2 0.0003
2 beta Lactamase Inhibitor [EPC] 1 0.0002
3 Vitamin K [EPC] 1 0.0001
4 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
5 Sigma-1 Agonist [EPC] 1 0.0001
6 Non-Standardized Plant Allergenic Extract [EPC] 2 0.0001
7 Platinum-based Drug [EPC] 30 0.0001
8 Quinolone Antimicrobial [EPC] 1 0.0001
9 Erythropoiesis-stimulating Agent [EPC] 5 0.0001
10 Topoisomerase Inhibitor [EPC] 6 0.0001
11 Asparagine-specific Enzyme [EPC] 1 0.0001
12 Prostaglandin E1 Analog [EPC] 1 0.0001
13 Vascular Endothelial Growth Factor Inhibitor [EPC] 11 0.0001
14 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
15 Antimetabolite Immunosuppressant [EPC] 1 0.0000
16 Thiazide-like Diuretic [EPC] 2 0.0000
17 Epidermal Growth Factor Receptor Antagonist [EPC] 2 0.0000
18 Nucleoside Metabolic Inhibitor [EPC] 11 0.0000
19 Calcineurin Inhibitor Immunosuppressant [EPC] 5 0.0000
20 Alkylating Drug [EPC] 9 0.0000
21 Microtubule Inhibitor [EPC] 6 0.0000
22 Phenothiazine [EPC] 1 0.0000
23 Glycopeptide Antibacterial [EPC] 2 0.0000
24 Leukocyte Growth Factor [EPC] 4 0.0000
25 Vitamin B12 [EPC] 9 0.0000
26 Vitamin D [EPC] 8 0.0000
27 Non-Standardized Food Allergenic Extract [EPC] 2 0.0000
28 Polyene Antifungal [EPC] 1 0.0000
29 Opioid Agonist [EPC] 6 0.0000
30 Vitamin C [EPC] 9 0.0000
31 Insulin [EPC] 1 0.0000
32 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
33 Aromatase Inhibitor [EPC] 2 0.0000
34 Methylxanthine [EPC] 1 0.0000
35 beta-Adrenergic Blocker [EPC] 5 0.0000
36 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
37 Nitroimidazole Antimicrobial [EPC] 1 0.0000
38 Expectorant [EPC] 3 0.0000
39 Androgen Receptor Inhibitor [EPC] 1 0.0000
40 Azole Antifungal [EPC] 2 0.0000
41 Arteriolar Vasodilator [EPC] 1 0.0000
42 Proton Pump Inhibitor [EPC] 7 0.0000
43 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
44 Nucleoside Analog Antiviral [EPC] 1 0.0000
45 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
46 Prostaglandin Analog [EPC] 1 0.0000
47 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
48 Benzodiazepine [EPC] 7 0.0000
49 Osmotic Laxative [EPC] 3 0.0000
50 Acetylcholine Release Inhibitor [EPC] 1 0.0000
51 Nonsteroidal Anti-inflammatory Drug [EPC] 13 0.0000
52 5-alpha Reductase Inhibitor [EPC] 1 0.0000
53 Antirheumatic Agent [EPC] 1 0.0000
54 Anti-epileptic Agent [EPC] 2 0.0000
55 Parathyroid Hormone Analog [EPC] 1 0.0000
56 Platelet Aggregation Inhibitor [EPC] 5 0.0000
57 Loop Diuretic [EPC] 4 0.0000
58 Proteasome Inhibitor [EPC] 1 0.0000
59 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
60 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
61 Sulfonylurea [EPC] 1 0.0000
62 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
63 Corticosteroid [EPC] 10 0.0000
64 Fluoroquinolone Antibacterial [EPC] 1 0.0000
65 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
66 Calcium [EPC] 1 0.0000
67 Aldosterone Antagonist [EPC] 1 0.0000
68 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
69 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
70 Estrogen [EPC] 1 0.0000
71 Thiazide Diuretic [EPC] 1 0.0000
72 Mood Stabilizer [EPC] 1 0.0000
73 Atypical Antipsychotic [EPC] 2 0.0000
74 Retinoid [EPC] 1 0.0000
75 Kinase Inhibitor [EPC] 2 0.0000
76 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
77 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
78 Thalidomide Analog [EPC] 1 0.0000